Quick links: United States | Major Indices | Indices Future | Real-time Commodities | Webinars | Coronavirus | Economic Calendar
Stock Market
Google executive to take over as a new CEO of Pinterest
Stock Market
Accounting firm gets 100 million fine for faulty regulations
Forex
The rupee tumbled to a new low against the dollar in the midst of an increase in crude oil price
Stock Market
Wall Street Lose Balance after recession strikes growth fear among consumers’
Stock Market
Inflation ringing the recession bell - Mohammed Shaheen
Coronavirus
27 Oct 2021
U.S. FDA to Authorize Pfizer/BioNTech COVID-19 Vaccine for Kids
The Index Today
Expert panel voted compellingly to recommend the U.S. Food and Drug Administration in authorizing the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of the shot overcome the risks.
An authorization for that age group of children would be an important regulatory step toward reaching about 28 million children for immunization, since most of kids are back in school for in-person learning.
The vaccine could be approved to the younger age group as soon as next week. The FDA is not obligated to follow the advice of its outside experts, but usually does. The vote was 17 in favor with one abstention, according to the Reuters.
Dr. Amanda Cohn, a pediatric vaccine expert at the CDC and a voting member of the panel, said "It is the eighth highest killer of kids in this age group over the past year." "Use of this vaccine will prevent deaths, will prevent ICU admissions and will prevent significant long-term adverse outcomes in children."
